Score Your Stock

ALPHA ALPHA IVF GROUP BERHAD

0303.KL · Health Care · Health Care Providers
Top 27% of scored stocks
Compare with nearby peers
OkayTop 27% of scored stocksLast year (FY2025): 80
Weak Spot

ALPHA scores 63/100 on fundamentals: in the top 27% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (100/100); its weakest is Price Fairness (0/100). It carries 1 warning flag: Weak Spot.

Best
Financial 100
Weakest
Price 0
  • Carries a Weak Spot flag
Mkt capRM 1.3b#168 of 1113 in BursaEPSRM 0.01P/E24.9×✓ vs sector avg 26.3×P/B6.9×✗ vs sector avg 1.6×Div yield4%✓ Top 22% in Bursa52w range · 36% of range0.230.34
as of 18 Oct 2026

Nearby peers

Ranks #7 of 30 in Health Care by score

#1DPHARMA85#5HARTA68#6PMCK67
#7ALPHA63
#8KPJ62#9TOPGLOV58

One-Minute Summary

Why ALPHA scores 63

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch

After Jun '26 results: 78 → 75−3· Quarterly Momentum Strong → OkaySee all movers →

Business Strength

80
Why 80?
Pillar score: (2 + 2 + 1 + 2 + 1) = 8 of 10 points → 80
Return on Equity (ROE)28%Strong4-Year Revenue Growth+13%/yrStrong4-Year Profit Growth+0%/yrOkayNet Profit Margin27%StrongQuarterly Momentum+12%Okay
Show 3 charts

Net Profit & Equity, with ROE

Net Profit → +0.8%Equity ↑ +267.6%ROE % 28.3%
Net ProfitEquityROE %
53m53m58m54m52m187m198m190m2023202420252026103.1%28.2%29%28.3%

Revenue & Net Profit, with Net Margin

Revenue ↑ +44.4%Net Profit → +0.8%Net Margin % 27%
RevenueNet ProfitNet Margin %
138m168m177m199m53m53m58m54m202320242025202638.7%31.6%32.5%27%

Sales grew about 44.4% over 4 years: customers keep spending more with this company.

Profit has moved sideways: stable, but not compounding your money faster each year.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +21.2%Net Profit ↓ -3.5%Net Margin % 26.7%
RevenueNet ProfitNet Margin %
43m43m41m50m52m47m47m52m14m15m12m16m15m12m13m14mAug '24Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '2633.5%35%29.3%32.2%29.2%25.4%26.5%26.7%
▲▼▲▲▼▲▼

Sales grew about 21.2% over the last 8 quarters: customers keep spending more with this company.

Profit has moved sideways over the last 8 quarters.

Why 100?
Pillar score: (2 + 2 + 2) = 6 of 6 points → 100
Debt-to-Equity0.2×StrongCurrent Ratio5.4×StrongInterest Coverage47.1×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +45.3%Equity ↑ +267.6%D/E 0.2×
Total DebtEquityD/E
23m16m24m34m52m187m198m190m20232024202520260.4×0.1×0.1×0.2×

Borrowings grew about 45.3% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +138.1%Current Liabilities ↑ +34.5%Current Ratio 5.4×
Current AssetsCurrent LiabilitiesCurrent Ratio
62m163m173m149m21m24m24m28m20232024202520263×6.8×7.3×5.4×
Why 88?
Pillar score: (1 + 2 + 2 + 2) = 7 of 8 points → 88
Dividend Quality4%Okay
Payout ratio: 90%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +10.1%Free CF ↓ -34.7%
Operating CFFree CF
61m59m55m67m60m50m48m39m2023202420252026

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↑ +85%Total Debt ↑ +45.3%
CashTotal Debt
20m23m34m37m23m16m24m34m2023202420252026

Dividends per Share, with Yield

DPS (sen) → +0%Yield % 4%
DPS (sen)Yield %
0010.520222023202420253.1%4%

Dividends were cut during this period: payouts here are not guaranteed pocket money.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ratio24.9×WeakP/B Ratio6.9×WeakPEG Ratio101.7Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.33RM 0.28RM 0.23100500score 80 → 63Oct '25Feb '26Jun '26Oct '26📊💰📊📊📊

The share price is down about 13% over the past year.

What happened, and how the price moved

After the last 4 results shown, the price beat the KLCI in the week of the news 3 times.

Why 50?
Pillar score: (1 + 0 + 2 + 2 + 0 + 1) = 6 of 12 points → 50
Earnings ConsistencyUnevenOkayDebt Trend (4yr)RisingWeakShare Count Trend (4yr)-0%/yrStrongInventory vs Sales (4yr)-2.7 pp/yr vs salesStrongAsset Turnover Trend (4yr)-45.7%WeakQuarterly Consistency2 of 4 quarters downOkay
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +44.4%Inventory ↑ +33.3%Inv. % of Rev. 1.8%
RevenueInventoryInv. % of Rev.
138m168m177m199m3m3m3m4m20232024202520262%1.7%1.6%1.8%

Get an email when ALPHA's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #7 of 30 in Health Care by score

Sector peers

#1DPHARMA85#5HARTA68#6PMCK67
#7ALPHA (you)63
#8KPJ62#9TOPGLOV58

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026RM 198.6mRM 53.6mRM 66.7mRM 39.0mRM -27.7mRM 37.0mRM 33.7m-RM 189.7mRM 148.6mRM 27.7mRM 254.9mRM 59.3mRM 3.6m-28%27%0.2×5.4×47.1×90%2%22.0×6.2×89.8
2025RM 176.8mRM 57.5mRM 54.9mRM 47.6mRM -7.3mRM 34.4mRM 23.5m-RM 198.0mRM 173.4mRM 23.8mRM 250.8mRM 46.7mRM 2.8mRM 0.5m29%32%0.1×7.3×71.2×80%2%22.3×6.5×0.4
2024RM 167.6mRM 52.9mRM 58.6mRM 50.2mRM -8.4mRM 22.9mRM 16.1mRM 0.0mRM 187.4mRM 162.5mRM 24.0mRM 228.3mRM 38.5mRM 2.9mRM 0.9m28%32%0.1×6.8×89.8×59%3%26.4×7.5×0.3
2023RM 137.5mRM 53.2mRM 60.6mRM 59.7mRM -0.9mRM 20.0mRM 23.2mRM 1.3mRM 51.6mRM 62.4mRM 20.6mRM 95.9mRM 41.3mRM 2.7mRM 0.0m103%39%0.5×3.0×67.1×-----